FOUNDER OF REVERSIBLE NEUROLOGY™

Personalized, root-cause neurology to change the trajectory of cognitive decline and chronic neurological disease.

Dr. Ken Sharlin combines advanced neurological diagnostics, functional medicine, systems biology, and regenerative medicine to identify what is driving neurological dysfunction—and create a personalized, measurable path toward better brain function.

What is Reversible Neurology™

Traditional neurology is often focused on diagnosing neurological disease, controlling symptoms, and

managing decline. Reversible Neurology™ asks an additional question: What factors contributing to

neurological dysfunction can still be identified, measured, and changed?

Dr. Sharlin combines conventional neurology with advanced diagnostics, functional medicine, systems

biology, lifestyle medicine, and regenerative approaches to identify potentially modifiable drivers of neurological dysfunction.

The objective is not to promise a cure. It is to create a personalized strategy designed to improve

function, address measurable contributors to disease, build neurological resilience, and—when

possible—change the trajectory of decline.

Hope is not a soft promise. It’s a biological reality when you know what to measure and what to change.

Real Patients. Measurable Change

2K+

Patients Helped

300+

Patient Testimonials

25 Years of Experience

Patient Results

Susan - Multiple Sclerosis

Presented with visual loss in one eye and dependency on a cane for mobility despite medication. Now, walks independently, has improved vision, and is no longer on disease-modifying therapy.

Theresa - Alzheimer’s Disease

Had MCI, with a family history of AD, faced severe cognitive decline, and loss of her driving license. Now, continues to live independently, drive, and has improved memory.

Robert - Parkinson's Disease

Suffered from debilitating tremors and gait instability that limited his ability to work. Now, largely asymptomatic and able to move around without the worry of falls and injury.

Richard - ALS (Lou Gehrig’s)

Experienced early signs of progressive weakness and speech difficulty. Has exceeded the odds of a 50% 2-year mortality, and continues to function, now more than 5 years since his diagnosis.